HomeZYXI • NASDAQ
Zynex Inc
$8.26
After Hours:
$8.26
(0.00%)0.00
Closed: Nov 22, 4:00:22 PM GMT-5 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$8.11
Day range
$8.13 - $8.30
Year range
$7.15 - $13.77
Market cap
263.04M USD
Avg Volume
109.69K
P/E ratio
55.78
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD)Sep 2024Y/Y change
Revenue
49.97M0.10%
Operating expense
36.08M3.19%
Net income
2.38M-33.72%
Net profit margin
4.77-33.75%
Earnings per share
0.07-33.01%
EBITDA
4.91M-25.73%
Effective tax rate
25.02%
Total assets
Total liabilities
(USD)Sep 2024Y/Y change
Cash and short-term investments
37.63M-28.24%
Total assets
126.06M-16.75%
Total liabilities
90.29M-2.76%
Total equity
35.77M
Shares outstanding
31.85M
Price to book
7.24
Return on assets
7.67%
Return on capital
8.71%
Net change in cash
(USD)Sep 2024Y/Y change
Net income
2.38M-33.72%
Cash from operations
7.07M-20.45%
Cash from investing
-72.00K99.28%
Cash from financing
-268.00K98.23%
Net change in cash
6.73M141.49%
Free cash flow
7.77M2.14%
About
Zynex, Inc. is a medical device manufacturer that produces and markets electrotherapy devices for use in pain management, physical rehabilitation, neurological diagnosis and cardiac monitoring. Thomas Sandgaard founded Zynex Medical in 1996. The company is based in unincorporated Douglas County, Colorado. Thomas Sandgaard serves as the company's CEO. Wikipedia
Founded
1996
Website
Employees
1,100
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu